Dr. Mariam Elgabry Will Use Her Grant to Build
Nurfy, the First AI-Powered Device to Bring Microbiome Health
Monitoring into the Home
GREENWICH, Conn., June 28,
2024 /PRNewswire/ -- O'Shaughnessy Ventures LLC
(OSV), an investment firm that empowers creators, has awarded an
O'Shaughnessy Fellowship to Dr. Mariam
Elgabry, an entrepreneur, scientist, and athlete based in
Athens, Greece.
Dr. Elgabry will continue to build Nurfy, an AI-powered device
designed to bring at-home microbiome health monitoring to
users.
Our microbiome is the collection of all microbes–such as
bacteria, fungi, viruses, and their genes–that naturally live on
and inside the body, whose health significantly impacts our own
health and wellbeing. Nurfy will combine advanced biosensing
technology with gamification principles to bring a sense of
community to microbiome health, with users receiving AI-powered
insights on their health status and ways to improve it.
After finalizing her prototype, Dr. Elgabry will plan for a
pilot launch to gather user feedback, collect data, and refine the
AI algorithms for microbiome analysis.
OSV's founder and CEO, Jim
O'Shaughnessy, commented, "In the coming years, AI-powered
technologies will have a profound effect on our ability to monitor
and improve our health. We are immensely impressed with Mariam's
experience and expertise in the field, and we look forward to
supporting her vision for a healthier world."
"I am beyond excited to be selected for the O'Shaughnessy
Fellowship," said Dr. Elgabry. "We don't have to imagine a world
where we interact with our health through everyday biotech–we're
building it. And Nurfy is just the beginning."
About Dr. Elgabry
Dr. Elgabry is an entrepreneur, scientist, and athlete on a
lifelong mission to understand the relationship between technology
and health. She holds a Ph.D. in biotechnology from University
College London and an M.Sc. in Theoretical Systems Biology from
Imperial College London, and was previously a Fellow at
Johns Hopkins University and Cyber
Fellow at Yale University.
As an inventor and researcher, Dr. Elgabry has both
entrepreneurial and academic expertise, with a patent and
publication record from award-winning projects at AstraZeneca and
Microsoft.
Dr. Elgabry is founder and CEO of the cyber-biosecurity company
Bronic, where she is combining her expertise in biotechnology with
her passion for running track in order to transform how individuals
interact with their health, while her research on the future of
biotechnology has been recognised by the UK Parliament Joint
Committee on National Security and the United Nations.
Outside of work, Dr. Elgabry is an avid kite surfer and
accomplished sprinter, who has represented the Greek National Team
in the 100- and 200-meter races.
More information about Dr. Elgabry is available on her
website.
About the Fellowship Program
OSV launched the O'Shaughnessy Fellowships in 2023. It is a
one-year program for ambitious people who want to build something
great. Fellows receive a $100,000
grant and access to OSV's network of founders, investors and
experts to support them in bringing their projects to life. More
information about last year's Fellows is available on OSV's
website.
In 2024, OSV will award ten $100,000 Fellowships. Applicants for the
Fellowships will also be considered for its sister program, the
O'Shaughnessy Grants. Under this program, OSV will make twenty
additional $10,000 grants to
promising creators, who will also be provided with access to OSV's
network.
Applications for the 2024 Fellowships are now closed and will
reopen on January 1, 2025. Creators
interested in learning more can visit OSV's website.
About O'Shaughnessy Ventures
OSV is a creative investment firm that empowers and inspires
creators to bring their ideas to life. Founded by Jim O'Shaughnessy, a pioneer in quantitative
investing, founder of O'Shaughnessy Asset Management, and author of
four books on investing, OSV aims to provide financial support and
to partner in growing the next life-changing creative ideas.
OSV combines Jim's deeply rooted interest in all things art,
science, investing, and tech with his long-held desire to establish
scenarios designed to help promising creators and their inspiring
ideas succeed, regardless of age, location, job history, or level
of education. For more information, visit https://www.osv.llc.
Media Contact:
Ena Gong
O'Shaughnessy Ventures LLC
(917) 355-7420
379711@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/oshaughnessy-ventures-awards-100-000-fellowship-grant-to-biotech-entrepreneur-aiming-to-revolutionize-microbiome-health-monitoring-302184724.html
SOURCE O'Shaughnessy Ventures